Tech Company Financing Transactions
Bluestar Genomics Funding Round
Bluestar Genomics closed a $70 million Series C funding round on 5/13/2021. Investors included private investors and Pathology Asia.
Transaction Overview
Company Name
Announced On
5/13/2021
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series C
Investors
private investors (Lead Investor) (Mattias Westman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
155 Bovet Rd. 400
San Mateo, CA 94402
USA
San Mateo, CA 94402
USA
Phone
Website
Email Address
Overview
Founded out of the Stanford laboratory of Steve Quake, Bluestar Genomics develops proprietary, next-generation epigenomic, and big data approaches to obtain comprehensive disease information about a patient -- with a simple and non-invasive sample -- that will be used to solve large healthcare market needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samuel Levy
Chief Medical Officer
Kelly Bethel
Vice President
Wayne Volkmuth
Browse more venture capital transactions:
Prev: 5/13/2021: Jellysmack venture capital transaction
Next: 5/13/2021: LumaTax venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs